Why Inflammation Could be the Newest Investable Opportunity in Alzheimer’s and Parkinson’s
Over the years, researchers have learned that chronic inflammation may be to blame in an increasing number of illnesses that were not originally thought to be inflammatory. Of course, inflammation has been implicated in many forms of arthritis and autoimmune diseases. Thus, targeting inflammation is becoming an even bigger and bigger market opportunity for biotech companies. According to one estimate, the global anti-inflammatory therapeutics market was worth $99.6 billion in 2021 and is expected to reach $127.5 billion by 2030 – a compound annual growth rate of 4.5% between 2022 and 2030. Tar...